Skip to main content
OpenTrials
Completed

NCT Number: NCT04890054

Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC

This study collects information to provide a model for how to rapidly adapt and scale-up multilevel interventions through clinic-health plan partnerships to reduce the burden of colorectal cancer (CRC) on the United states population. This study may improve colorectal cancer screening rates, follow-up colonoscopy, and referral to care in rural Medicaid patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

OHSU Knight Cancer Institute

Portland, Oregon, 97239, United States

About this study

PRIMARY OBJECTIVE:

I. Adapt, pilot, then test the implementation and scale-up of targeted direct mail and patient navigation programs.

OUTLINE:

This is an implementation-effectiveness trial of direct mail outreach and patient navigation intervention to improve rates of CRC screening. Eligible patients will be mailed a fecal immunochemical test (FIT). The mailed FIT and patient navigation interventions are a part of standard care and are carried out by the Medicaid health plan or clinic. Outcomes are tracked using reports from direct mail vendors, claims data from participating Medicaid health plans, clinic data from the electronic health record, chart review, and data from a REDCap database. The hypotheses will be tested using a two-arm cluster randomized trial design. Participating clinics will be randomized into two groups: Intervention and Usual Care. Medicaid health plans/ Coordinated care organizations (CCO) and clinic leadership participate in interviews and complete surveys.

The primary effectiveness outcome of this study is CRC screening likelihood in eligible Medicaid patients in intervention and control clinics at 6 months. Data will be collected at 6 time points: baseline, 6-months, 12-months, 18-months, 24-months, and 36-months.

Implementation outcomes and adaptations will be evaluated through interviews with clinic staff, patients, and CCO partners. Clinic staff in various roles related to the program (e.g., outreach workers, patient navigators, quality improvement leads) complete surveys and participate in interviews and observations at baseline, 6-9 months (post-implementation) and at approximately 12 months later, to assess clinic/health system level factors that may influence outcomes. Patients participate in interviews to explore patient experiences with the program. Regional and Organizational partners: CCO leaders, endoscopy providers (e.g., gastrointestinal specialists, general surgeons, primary care clinicians), and community organizations also participate in interviews.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • CCOs/CCO STAFF: Serving a majority of counties that are predominantly rural based on 2010 Rural-Urban Commuting Area (RUCA) codes (codes 4-10)
  • CCOs/CCO STAFF: Willing to participate in data collection activities (e.g., producing claims data, interviews)
  • CLINICS: Clinics will be eligible for the cluster randomization if there are 30 or more patients eligible for screening
  • CLINICS: Are classified as rural according to RUCA (Codes 4-10) or Oregon Office of Rural Health designations
  • CLINICS: Are served by CCOs agreeing to participate in the project
  • CLINICS: Willing to implement the intervention into their clinic for the study
  • CLINIC STAFF/PROVIDERS: Employed as a clinician or ancillary staff member in a participating clinic
  • CLINIC STAFF/PROVIDERS: Willing to participate in data collection activities (e.g., interviews, observation, surveys)
  • PATIENTS: Attributed to participating clinic
  • PATIENTS: Are enrolled in Medicaid or dual eligible
  • PATIENTS: Eligible for colorectal cancer (CRC) screening
  • PATIENTS: For the subset of patients that will be invited to participate in key informant interviews, a 5th eligibility criteria is consented to participate
  • COMMUNITY OR REGIONAL/ORGANIZATIONAL PARTNERS: (Includes endoscopy providers, community-based outreach workers, or leaders from regional or national organizations who participate in the pilot, pragmatic trial, or scale-up study)
  • COMMUNITY OR REGIONAL/ORGANIZATIONAL PARTNERS: Involved in study activities (training, care delivery)
  • COMMUNITY OR REGIONAL/ORGANIZATIONAL PARTNERS: Willing to participate in data collection activities (e.g., trainings, interviews, surveys)
  • Elderly - Yes - we anticipate that a limited number of clinic and CCO staff, or community organization representatives may be elderly; we limit our patient recruitment to those aged 45-75
  • Rural - Yes
  • Inner city - No
  • Low income - Yes
  • Disabled - Yes
  • Chronic care - Yes
  • End of life - Yes - This is possible, but we predict limited numbers because of the types of individuals we are recruiting: clinic and CCO staff, and patients who are not currently in hospice care
  • Minorities - Yes

Exclusion criteria

  • CLINICS: Clinics are excluded if they have current or ongoing participating in other mailed fecal testing research projects in the Medicaid population
  • PATIENTS: Are current for screening
  • PATIENTS: Comorbid conditions that make patients poor candidates for screening based on clinical judgment (e.g., end-stage renal disease, enrollment in hospice)
  • PATIENTS: Are not an established patient or for other reasons documented by the clinics
  • All patients that we recruit will be at least 45 years of age or older

Treatment and study plan

Fecal Immunochemical Test

Other

Patients due for CRC screening are mailed a FIT test by the clinic or health plan

Other names: FIT, iFOBT, immunoassay fecal occult blood test, immunochemical fecal occult blood test, Immunochemical FOBT, immunologic fecal occult blood test

interview

Other

Participate in interviews to evaluate the implementation of the mailed FIT and patient navigation programs by the clinics and regional organizations

Patient Navigation

Behavioral

Clinic staff are trained in Navigation, patients with an abnormal FIT are contacted about colonoscopy by patient navigators

Other names: Patient Navigator Program

Primary outcomes

  1. Likelihood of Any Colorectal Cancer (CRC) Screening (for Study-eligible Patients)

    Time frame: Primary outcome at 6 months following CCO eligible patient list pull date,

    Adjusted 6-month any CRC screening for enrollees in clinic units. These values are predicted estimates rather than crude number [%] generated using marginal standardization and accounting for clustering and covariates (i.e., sex, age, and Medicaid health plan). Claims and vendor data were used to determine whether or not the patient completed CRC screening (i.e., fecal testing, FIT-DNA, sigmoidoscopy, CT colonography, or colonoscopy). To assess effectiveness of CRC screening completion, we used the generalized form of hierarchical linear model (binomial distribution with logit link) to account for clustering of patients within clinics and the assignment to arm at the clinic level.

Secondary outcomes

  1. Completion of CRC Screening

    Time frame: Up to 12 months

    Completed CRC screening at 12 months. Claims and vendor data were used to determine whether or not the patient completed CRC screening (i.e., fecal testing, FIT-DNA, sigmoidoscopy, CT colonography, or colonoscopy).

  2. Rate of CRC Screening Among the Intervention-eligible Population

    Time frame: 6 months

    In the intervention clinics only, the list of patients eligible for screening was scrubbed by clinics. This percent is the N completed CRC screening out of the N included in intervention outreach after clinics scrubbed the list of eligible patients.

  3. Time to Screening From Study-eligible Patient List Pull

    Time frame: Up to 12 months

    Days from study-eligible patient list pull to abnormal FIT result. Number of days at individual level.

  4. Abnormal FIT Results

    Time frame: 6 months

    Number of participants with abnormal FIT Results

  5. Patient Navigation Trainings (Intervention Group)

    Time frame: Up to 12 months

    Clinic participation (i.e., attendance) in patient navigation training, Year 1 clinical trial

  6. Patient Navigation Completed (Intervention Group)

    Time frame: Up to 12 months

    Patient navigation implemented = one or more live phone contact with the patient (binary at the individual level).

  7. Follow-up Colonoscopy Completion

    Time frame: Up to 12 months

    The percentage of patients with abnormal FIT who completed follow-up colonoscopy within 12 months

  8. Time to Colonoscopy From Abnormal FIT Result

    Time frame: Up to 12 months

    Days from abnormal FIT result to completion of follow-up colonoscopy. Number of days at the individual level.

  9. Adenomas or Cancers Detected

    Time frame: Up to 12 months

    Whether or not eligible patient had an adenoma or cancer detected. Binary at individual level.

  10. Key Implementation Barriers

    Time frame: Up to 36 months

    Qualitative key informant interviews with clinic and payer stakeholders to identify implementation barriers.

Sponsors and collaborators

Lead sponsor

OHSU Knight Cancer Institute

Other

Collaborators

  • National Cancer Institute (NCI)
  • Oregon Health and Science University

Registry information

Official study title

Screening More Patients for CRC Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings (SMARTER CRC)

Acronym: SMARTER CRC

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
May 18, 2021
Registry last updated
Aug 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.